Review of various NAMPT inhibitors for the treatment of cancer

Y Wei, H Xiang, W Zhang - Frontiers in Pharmacology, 2022 - frontiersin.org
Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in the NAD
salvage pathway of mammalian cells and is overexpressed in numerous types of cancers …

Recent advances in NAMPT inhibitors: a novel immunotherapic strategy

U Galli, G Colombo, C Travelli, GC Tron… - Frontiers in …, 2020 - frontiersin.org
Nicotinamide adenine dinucleotide (NAD) is a cofactor of many enzymatic reactions as well
as being a substrate for a number of NAD-consuming enzymes (eg, PARPS, sirtuins, etc) …

Recent advances of targeting nicotinamide phosphoribosyltransferase (NAMPT) for cancer drug discovery

H Tang, L Wang, T Wang, J Yang, S Zheng… - European Journal of …, 2023 - Elsevier
Highlights•NAMPT is overexpressed in cancers, associating with a poor prognosis and
tumor progression.•Extensive efforts have been made to improve efficacy and safety of early …

Beyond energy metabolism: exploiting the additional roles of NAMPT for cancer therapy

CM Heske - Frontiers in oncology, 2020 - frontiersin.org
Tumor cells have increased requirements for NAD+. Thus, many cancers exhibit an
increased reliance on NAD+ production pathways. This dependence may be exploited …

Advances in NAD-lowering agents for cancer treatment

MS Ghanem, F Monacelli, A Nencioni - Nutrients, 2021 - mdpi.com
Nicotinamide adenine dinucleotide (NAD) is an essential redox cofactor, but it also acts as a
substrate for NAD-consuming enzymes, regulating cellular events such as DNA repair and …

NAD-and NADPH-contributing enzymes as therapeutic targets in cancer: an overview

AA Pramono, GM Rather, H Herman, K Lestari… - Biomolecules, 2020 - mdpi.com
Actively proliferating cancer cells require sufficient amount of NADH and NADPH for
biogenesis and to protect cells from the detrimental effect of reactive oxygen species. As …

Pancreatic cancer chemo-resistance is driven by tumor phenotype rather than tumor genotype

M Swayden, J Iovanna, P Soubeyran - Heliyon, 2018 - cell.com
Abstract Pancreatic Ductal Adenocarcinoma (PDAC) is one of the deadliest forms of cancer.
A major reason for this situation is the fact that these tumors are already resistant or become …

Adipokines and epithelial-mesenchymal transition (EMT) in cancer

I Akrida, H Papadaki - Molecular and Cellular Biochemistry, 2023 - Springer
Obesity is a significant risk factor for cancer development. Within the tumor
microenvironment, adipocytes interact with cancer cells, immune cells, fibroblasts and …

α-Ketoglutarate supplementation and NAD+ modulation enhance metabolic rewiring and radiosensitization in SLC25A1 inhibited cancer cells

K Xiang, M Kunin, S Larafa, M Busch, N Dünker… - Cell Death …, 2024 - nature.com
Metabolic rewiring is the result of the increasing demands and proliferation of cancer cells,
leading to changes in the biological activities and responses to treatment of cancer cells …

NAD+ deficits in age-related diseases and cancer

A Garrido, N Djouder - Trends in cancer, 2017 - cell.com
The phenomenon of aging has gained widespread attention in recent times. Although
significant advances have been made to better understand aging and its related pathologies …